Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05531474

Bariatric Surgery for the Reduction of Cardiovascular Events Randomized Controlled Trial

Led by Population Health Research Institute · Updated on 2026-05-28

700

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of bariatric surgery compared to medical weight management (MWM) in patients with severe obesity and high-risk cardiovascular disease (CVD). The study aims to determine if bariatric surgery can safely reduce the risk of major cardiovascular events. It also examines the cost-effectiveness of bariatric surgery and includes additional sub-studies on mental health, cognition, cardiac structure and function, and molecular profiling. Participants will be randomly assigned to receive either bariatric surgery or medical weight management. Bariatric surgery options include gastric bypass, sleeve gastrectomy, or duodenal switch, chosen by the surgeon. Medical weight management involves standard care such as dietary, lifestyle, and behavioral counseling, which may include low-calorie diets, meal replacements, or anti-obesity medications based on local practices. Surgery patients may receive a low-fat, high-protein meal replacement before the procedure, and perioperative care follows local guidelines. During the study, participants will be monitored for cardiovascular outcomes over an average of 6 years, with additional mental health and cognition assessments at 3 years. The study tracks events like heart attacks, strokes, hospitalizations, diabetes status, and heart rhythm changes. Researchers will also analyze cost-effectiveness in quality adjusted life years. Safety and health status will be regularly assessed, and participant involvement includes ongoing follow-up visits and evaluations throughout the study period.

CONDITIONS

Brief Title

Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Body mass index (BMI) of 30 kg/m2 or higher; OR BMI 30 to 34.9 kg/m2 with type 2 diabetes or age over 55 years
  • Age 18 years or older
  • High-risk cardiovascular disease, defined by any of the following:
    • History of major coronary artery disease events or significant artery blockages
    • Left ventricular ejection fraction less than 40%
    • Heart failure with preserved ejection fraction and recent hospitalization or elevated natriuretic peptides
    • Documented atrial fibrillation with stroke risk score of 2 or higher
    • History of any stroke
    • Documented peripheral arterial disease with specific criteria
Not Eligible

You will not qualify if you...

  • Hospital admission for heart failure, myocardial infarction, stroke, or coronary revascularization within 30 days before randomization
  • Percutaneous coronary intervention with a drug eluting stent within 90 days before randomization
  • Pregnancy
  • Contraindication to bariatric surgery
  • Prior bariatric surgery other than gastric banding
  • Life expectancy under 2 years from non-cardiovascular causes
  • Inability to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 6 years

Participants receive either bariatric surgery or medical weight management according to local practice standards.

Visits occur as needed for surgery and regular medical weight management follow-up

Follow-up

Duration - Up to 6 years

Participants are monitored for cardiovascular outcomes and other health measures after treatment.

Long-term follow-up visits over approximately 6 years

Trial Site Locations

Total: 1 location

1

Hamilton Health Sciences

Hamilton, Ontario, Canada, L8L 2X2

Actively Recruiting

Loading map...

Research Team

J

Jorge Wong, MD, MPH, FRCPC

S

Sumathy Rangarajan, MSc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

9-Step Magnetic Assisted Conversion From Sleeve Gastrectomy ...

Bariatric Surgery Candidate

Actively Recruiting

1 location

A Randomized, Placebo-controlled Trial of Dapagliflozin for ...

Gestational Hypertension

Actively Recruiting

1 location

Evaluation of Efficiency and Complications of Laparoscopic A...

Bariatric Surgery Candidate

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here